PERRIGO Co plc (PRGO)

↓ Download CSV

CIK 0001585364 · NYSE · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated L2
  • Fiscal year ends Dec 31

In fiscal 2025, PERRIGO Co plc reported revenue of $4.25B, down 2.8% from the prior year. The company ran a net loss, with a net margin of -33.5% and a gross margin of 35.1%. It held $8.54B in total assets against $5.60B in total liabilities.

Key ratios (FY2025)

35.1%
Gross margin
-26.4%
Operating margin
-33.5%
Net margin
-48.6%
Return on equity
-2.8%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$4.25B$4.37B$4.66B$4.45B$4.14B$4.09B$3.87B$4.73B$4.95B$5.28B
Cost of Revenue$2.76B$2.83B$2.98B$3.00B$2.72B$2.59B$2.44B$2.90B$2.97B$3.23B
Gross Profit$1.49B$1.54B$1.68B$1.46B$1.42B$1.49B$1.43B$1.83B$1.98B$2.05B
Operating Income-$1.12B$112.90M$151.90M$78.90M$410.40M$265.20M$174.70M$236.50M$598.20M-$2.00B
Net Income-$1.43B-$171.80M-$12.70M-$140.60M-$68.90M-$162.60M$146.10M$131.00M$119.60M-$4.01B
EPS (Diluted)$-10.29$-1.25$-0.09$-1.04$-0.52$-1.19$1.07$0.95$0.84$-28.01
Total Assets$8.54B$9.65B$10.81B$11.02B$10.43B$11.49B$11.30B$10.98B$11.63B$13.87B
Total Liabilities$5.60B$5.33B$6.04B$6.18B$5.27B$5.83B$5.50B$5.32B$5.46B$7.91B
Shareholders' Equity$2.94B$4.32B$4.77B$4.84B$5.15B$5.66B$5.80B$5.67B$6.17B$5.96B
Cash & Equivalents$600.70M$1.86B$631.50M$354.30M$551.10M$678.70M$622.30M
Operating Cash Flow$238.50M$362.90M$405.50M$307.30M$156.30M$636.20M$387.80M$593.00M$698.90M$654.90M
Capital Expenditures$93.40M$118.30M$101.70M$96.40M$152.10M$170.40M$137.70M$102.60M$88.60M$106.20M
Shares Outstanding138.50M137.40M135.30M134.50M133.60M137.20M136.50M138.30M142.60M143.30M
Dividends Per Share$1.16$1.10$1.09$1.04$0.96$0.90$0.82$0.76$0.64$0.58